Table 1.
Characteristics of HIV-uninfected and HIV-infected Hodgkin lymphoma cases in 14 U.S. SEER registries, 2000–2010
| HIV-uninfected | HIV-infected | |
|---|---|---|
| N (%) | N (%) | |
| Total | 21,507 (100) | 848 (100) |
| Sex | ||
| Male | 11,539 (53.7) | 731 (86.2) |
| Female | 9,968 (46.4) | 117 (13.8) |
| Age group | ||
| 0–9 | 314 (1.5) | 1 (0.1) |
| 10–19 | 2,369 (11.5) | 10 (1.2) |
| 20–29 | 4,814 (22.4) | 73 (8.6) |
| 30–39 | 3,848 (17.9) | 220 (25.9) |
| 40–49 | 2,994 (13.9) | 305 (36.0) |
| 50–59 | 2,262 (10.5) | 178 (21.0) |
| 60–69 | 1,983 (9.2) | 38 (4.5) |
| 70+ | 2,823 (13.1) | 23 (2.7) |
| Race/ethnicity | ||
| Non-Hispanic white | 14,778 (68.7) | 343 (40.5) |
| Non-Hispanic black | 2,105 (9.8) | 225 (30.1) |
| Hispanic | 3,347 (15.6) | 229 (27.0) |
| Other | 1,277 (5.9) | 21 (2.5) |
| Registry HIV prevalence | ||
| Below national average | 9,917 (46.1) | 264 (31.1) |
| Above national average | 11,590 (53.9) | 584 (68.9) |
| Histological subtype | ||
| Lymphocyte-rich | 679 (3.2) | 16 (1.9) |
| Mixed cellularity | 2,632 (12.2) | 212 (25.0) |
| Lymphocyte-depleted | 268 (1.3) | 31 (3.7) |
| Nodular sclerosis | 12,819 (59.6) | 260 (30.7) |
| Classical NOS | 4,160 (19.3) | 321 (37.9) |
| Nodular lymphocyte predominant | 949 (4.4) | 8 (0.9) |
| Ann Arbor Stage | ||
| Stage I | 3,956 (18.4) | 121 (14.3) |
| Stage II | 8,489 (39.5) | 149 (17.6) |
| Stage III | 4,115 (19.1) | 190 (22.4) |
| Stage IV | 3,660 (17.0) | 352 (41.5) |
| Unknown | 1,287 (6.0) | 36 (4.3) |
| “B” Symptoms | ||
| Absent | 9,445 (43.9) | 245 (28.9) |
| Present | 7,356 (34.2) | 487 (57.4) |
| Unknown | 4,706 (21.9) | 116 (13.7) |